Business and Innovation

Stem cells hold great promise, but is it the cells we really need?

So much of premium IOL selection comes down to chair time and questionnaires. But what if it didn’t?

A noninvasive method to monitor disease in the eye.

Sustained-release drug delivery technologies over time, and how future innovators should proceed…

My words of wisdom on working with industry to drive ophthalmic innovation.

The behind-the-scenes story of Oculeve.

Richard Lindstrom, Chairman and Founder of Minnesota Eye Consultants, Minneapolis, Minnesota, USA.

This month’s approvals, acquisitions, revenue reports, regulatory action and trial results.

The long and controversial journey to microinvasive glaucoma surgery (MIGS), and the quest to retire trabeculectomy

Acquisitions, funding rounds, approvals and IP this month